Erratum: ISG15 Regulates Peritoneal Macrophages Functionality against Viral Infection (PLoS Pathogens (2013) 9:10 (e1003632) DOI: 10.1371/journal.ppat.1003632);ISG15 Regulates Peritoneal Macrophages Functionality against Viral Infection

PLoS Pathogens

Volumn 9, Issue 10, 2013, Pages

  Yángüez, Emilio ^a   García Culebras, Alicia ^b   Frau, Aldo ^b   Llompart, Catalina ^c,d   Knobeloch, Klaus Peter ^e   Gutierrez Erlandsson, Sylvia ^c   García Sastre, Adolfo ^f   Esteban, Mariano ^c   Nieto, Amelia ^c,d   Guerra, Susana ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e UNIVERSITY OF FREIBURG   (Germany)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 7; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; VIRUS PROTEIN;

ANIMAL CELL; ANTIVIRAL ACTIVITY; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL ISOLATION; CELL PHAGOCYTOSIS; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; FIBROBLAST; GENE; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNOFLUORESCENCE TEST; INTERFERON STIMULATED GENE PRODUCT 15 GENE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; VACCINIA VIRUS; VIRUS INFECTION; WESTERN BLOTTING;

MURINAE; MUS; VACCINIA VIRUS;

ANIMALS; CELLS, CULTURED; CYTOKINES; FIBROBLASTS; HUMANS; IMMUNITY, INNATE; INTERFERON-GAMMA; MACROPHAGES, PERITONEAL; MICE; MICE, KNOCKOUT; PROTO-ONCOGENE PROTEINS C-AKT; UBIQUITINS; VACCINIA; VACCINIA VIRUS;

EID: 84887306533     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005969     Document Type: Erratum

References (53)

1. Sledz CA, Holko M, de Veer MJ, Silverman RH, Williams BR, (2003) Activation of the interferon system by short-interfering RNAs. Nat Cell Biol 5: 834-839.
2. Sadler AJ, Williams BR, (2008) Interferon-inducible antiviral effectors. Nat Rev Immunol 8: 559-568.
3. Au WC, Moore PA, Lowther W, Juang YT, Pitha PM, (1995) Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes. Proc Natl Acad Sci U S A 92: 11657-11661.
4. Zhao C, Denison C, Huibregtse JM, Gygi S, Krug RM, (2005) Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc Natl Acad Sci U S A 102: 10200-10205.
5. D'Cunha J, Knight E Jr, Haas AL, Truitt RL, Borden EC, (1996) Immunoregulatory properties of ISG15, an interferon-induced cytokine. Proc Natl Acad Sci U S A 93: 211-215.
6. Recht M, Borden EC, Knight E Jr, (1991) A human 15-kDa IFN-induced protein induces the secretion of IFN-gamma. J Immunol 147: 2617-2623.
7. Lenschow DJ, Lai C, Frias-Staheli N, Giannakopoulos NV, Lutz A, et al. (2007) IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc Natl Acad Sci U S A 104: 1371-1376.
8. Giannakopoulos NV, Arutyunova E, Lai C, Lenschow DJ, Haas AL, et al. (2009) ISG15 Arg151 and the ISG15-conjugating enzyme UbE1L are important for innate immune control of Sindbis virus. J Virol 83: 1602-1610.
9. Kim JH, Luo JK, Zhang DE, (2008) The level of hepatitis B virus replication is not affected by protein ISG15 modification but is reduced by inhibition of UBP43 (USP18) expression. J Immunol 181: 6467-6472.
10. Guerra S, Caceres A, Knobeloch KP, Horak I, Esteban M, (2008) Vaccinia virus E3 protein prevents the antiviral action of ISG15. PLoS Pathog 4: e1000096.
11. Ritchie KJ, Hahn CS, Kim KI, Yan M, Rosario D, et al. (2004) Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection. Nat Med 10: 1374-1378.
12. Knobeloch KP, Utermohlen O, Kisser A, Prinz M, Horak I, (2005) Reexamination of the role of ubiquitin-like modifier ISG15 in the phenotype of UBP43-deficient mice. Mol Cell Biol 25: 11030-11034.
13. Osiak A, Utermohlen O, Niendorf S, Horak I, Knobeloch KP, (2005) ISG15, an interferon-stimulated ubiquitin-like protein, is not essential for STAT1 signaling and responses against vesicular stomatitis and lymphocytic choriomeningitis virus. Mol Cell Biol 25: 6338-6345.
14. Moore EC, Barber J, Tripp RA, (2008) Respiratory syncytial virus (RSV) attachment and nonstructural proteins modify the type I interferon response associated with suppressor of cytokine signaling (SOCS) proteins and IFN-stimulated gene-15 (ISG15). Virol J 5: 116.
15. Okumura A, Lu G, Pitha-Rowe I, Pitha PM, (2006) Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. Proc Natl Acad Sci U S A 103: 1440-1445.
16. Okumura A, Pitha PM, Harty RN, (2008) ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity. Proc Natl Acad Sci U S A 105: 3974-3979.
17. Werneke SW, Schilte C, Rohatgi A, Monte KJ, Michault A, et al. (2011) ISG15 is critical in the control of Chikungunya virus infection independent of UbE1L mediated conjugation. PLoS Pathog 7: e1002322.
18. Lai C, Struckhoff JJ, Schneider J, Martinez-Sobrido L, Wolff T, et al. (2009) Mice lacking the ISG15 E1 enzyme UbE1L demonstrate increased susceptibility to both mouse-adapted and non-mouse-adapted influenza B virus infection. J Virol 83: 1147-1151.
19. Giannakopoulos NV, Luo JK, Papov V, Zou W, Lenschow DJ, et al. (2005) Proteomic identification of proteins conjugated to ISG15 in mouse and human cells. Biochem Biophys Res Commun 336: 496-506.
20. Durfee LA, Lyon N, Seo K, Huibregtse JM, (2010) The ISG15 conjugation system broadly targets newly synthesized proteins: implications for the antiviral function of ISG15. Mol Cell 38: 722-732.
21. Okumura F, Okumura AJ, Uematsu K, Hatakeyama S, Zhang DE, et al. (2012) Activation of double-stranded RNA-activated protein kinase (PKR) by interferon stimulated gene 15 (ISG15) modification down-regulates protein translation. J Biol Chem 288 (4) ():: 2839-47.
22. Malakhov MP, Kim KI, Malakhova OA, Jacobs BS, Borden EC, et al. (2003) High-throughput immunoblotting. Ubiquitiin-like protein ISG15 modifies key regulators of signal transduction. J Biol Chem 278: 16608-16613.
23. Malakhova OA, Zhang DE, (2008) ISG15 inhibits Nedd4 ubiquitin E3 activity and enhances the innate antiviral response. J Biol Chem 283: 8783-8787.
24. Kim MJ, Yoo JY, (2010) Inhibition of hepatitis C virus replication by IFN-mediated ISGylation of HCV-NS5A. J Immunol 185: 4311-4318.
25. Bratosin D, Mazurier J, Slomianny C, Aminoff D, Montreuil J, (1997) Molecular mechanisms of erythrophagocytosis: flow cytometric quantitation of in vitro erythrocyte phagocytosis by macrophages. Cytometry 30: 269-274.
26. Tang Y, Zhong G, Zhu L, Liu X, Shan Y, et al. (2010) Herc5 attenuates influenza A virus by catalyzing ISGylation of viral NS1 protein. J Immunol 184: 5777-5790.
27. Zhao C, Hsiang TY, Kuo RL, Krug RM, (2010) ISG15 conjugation system targets the viral NS1 protein in influenza A virus-infected cells. Proc Natl Acad Sci U S A 107: 2253-2258.
28. Bogunovic D, Byun M, Durfee LA, Abhyankar A, Sanal O, et al. (2012) Mycobacterial disease and impaired IFN-gamma immunity in humans with inherited ISG15 deficiency. Science 337: 1684-1688.
29. Melkova Z, Esteban M, (1994) Interferon-gamma severely inhibits DNA synthesis of vaccinia virus in a macrophage cell line. Virology 198: 731-735.
30. Soldani C, Scovassi AI, (2002) Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: an update. Apoptosis 7: 321-328.
31. Marti-Lliteras P, Regueiro V, Morey P, Hood DW, Saus C, et al. (2009) Nontypeable Haemophilus influenzae clearance by alveolar macrophages is impaired by exposure to cigarette smoke. Infect Immun 77: 4232-4242.
32. Hsiang TY, Zhao C, Krug RM, (2009) Interferon-induced ISG15 conjugation inhibits influenza A virus gene expression and replication in human cells. J Virol 83: 5971-5977.
33. Aderem A, Underhill DM, (1999) Mechanisms of phagocytosis in macrophages. Annu Rev Immunol 17: 593-623.
34. Au WC, Moore PA, LaFleur DW, Tombal B, Pitha PM, (1998) Characterization of the interferon regulatory factor-7 and its potential role in the transcription activation of interferon A genes. J Biol Chem 273: 29210-29217.
35. Skaug B, Chen ZJ, (2010) Emerging role of ISG15 in antiviral immunity. Cell 143: 187-190.
36. Barber GN, (2001) Host defense, viruses and apoptosis. Cell Death Differ 8: 113-126.
37. Teodoro JG, Branton PE, (1997) Regulation of apoptosis by viral gene products. J Virol 71: 1739-1746.
38. Joffre OPSE, Savina A, Amigorena S, (2012) Cross-presentation by dendritic cells. Nat Rev Immunol 12: 557-569.
39. Smith KG, Clatworthy MR, (2010) FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications. Nat Rev Immunol 10: 328-343.
40. Hemmings BA, Restuccia DF, (2012) PI3K-PKB/Akt pathway. Cold Spring Harb Perspect Biol 4: a011189.
41. Li E, Stupack D, Klemke R, Cheresh DA, Nemerow GR, (1998) Adenovirus endocytosis via alpha(v) integrins requires phosphoinositide-3-OH kinase. J Virol 72: 2055-2061.
42. Kierbel A, Gassama-Diagne A, Mostov K, Engel JN, (2005) The phosphoinositol-3-kinase-protein kinase B/Akt pathway is critical for Pseudomonas aeruginosa strain PAK internalization. Mol Biol Cell 16: 2577-2585.
43. Dunn EF, Connor JH, (2012) HijAkt: The PI3K/Akt pathway in virus replication and pathogenesis. Prog Mol Biol Transl Sci 106: 223-250.
44. Izmailyan RHJ, Chung CS, Chen CH, Hsu PW, Liao CL, et al. (2012) Integrin β1 mediates vaccinia virus entry through activation of PI3K/Akt signaling. J Virol 86: 10.
45. Kaur S, Sassano A, Dolniak B, Joshi S, Majchrzak-Kita B, et al. (2008) Role of the Akt pathway in mRNA translation of interferon-stimulated genes. Proc Natl Acad Sci U S A 105: 4808-4813.
46. Deretic V, Singh S, Master S, Harris J, Roberts E, et al. (2006) Mycobacterium tuberculosis inhibition of phagolysosome biogenesis and autophagy as a host defence mechanism. Cell Microbiol 8: 719-727.
47. Guerra S, Lopez-Fernandez LA, Pascual-Montano A, Munoz M, Harshman K, et al. (2003) Cellular gene expression survey of vaccinia virus infection of human HeLa cells. J Virol 77: 6493-6506.
48. Arakawa Y, Cordeiro JV, Schleich S, Newsome TP, Way M, (2007) The release of vaccinia virus from infected cells requires RhoA-mDia modulation of cortical actin. Cell Host Microbe 1: 227-240.
49. Tobita K, Sugiura A, Enomote C, Furuyama M, (1975) Plaque assay and primary isolation of influenza A viruses in an established line of canine kidney cells (MDCK) in the presence of trypsin. Med Microbiol Immunol 162: 9-14.
50. Guerra S, Aracil M, Conde R, Bernad A, Esteban M, (2005) Wiskott-Aldrich syndrome protein is needed for vaccinia virus pathogenesis. J Virol 79: 2133-2140.
51. Garcia MA, Guerra S, Gil J, Jimenez V, Esteban M, (2002) Anti-apoptotic and oncogenic properties of the dsRNA-binding protein of vaccinia virus, E3L. Oncogene 21: 8379-8387.
52. Fujimoto I, Pan J, Takizawa T, Nakanishi Y, (2000) Virus clearance through apoptosis-dependent phagocytosis of influenza A virus-infected cells by macrophages. J Virol 74: 3399-3403.
53. Cordeiro JV, Guerra S, Arakawa Y, Dodding MP, Esteban M, et al. (2009) F11-mediated inhibition of RhoA signalling enhances the spread of vaccinia virus in vitro and in vivo in an intranasal mouse model of infection. PLoS One 4: e8506.